Completed PHASE3 INTERVENTIONAL 3-arm NCT04051710

Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH (QVR)

Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate Efficacy and Safety of Beclomethasone Dipropionate Metered Dose Inhaler (Inhalation Aerosol) (0.04mg/ INH) in Male and/ or Female Subjects With Asthma

Sponsor: Aurobindo Pharma Ltd

Conditions Bronchial Asthma

Interventions Placebo Reference Product Test Product

Updated 8 times since 2019 Last updated: Oct 22, 2020 Started: Mar 12, 2019 Primary completion: Aug 29, 2019 Completion: Dec 20, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Bronchial Asthma and is currently completed. Aurobindo Pharma Ltd leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3
Jan 2021 — Dec 2022 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Dec 2020 — Jan 2021 [monthly]

Completed PHASE3
Apr 2020 — Dec 2020 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Sep 2019 — Apr 2020 [monthly]

Recruiting PHASE3

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aurobindo Pharma Ltd

Data source: Aurobindo Pharma Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pune, India